SCHEMBL5825296

SCHEMBL5825296

COc1cc2nccc(Oc3ccc(NC(=O)OC(C)c4ccc(F)cc4)c(C)c3C)c2cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 10/20 0.60
AXL P30530 5/20 0.60
PDGFRA P16234 7/20 0.54
KDR P35968 9/20 0.53
KIT P10721 3/20 0.52
FGFR2 P21802 2/20 0.52
FLT4 P35916 2/20 0.50
FLT3 P36888 2/20 0.50
MST1R Q04912 2/20 0.50
SRC P12931 2/20 0.49
TGFBR1 P36897 1/20 0.49
AURKA O14965 1/20 0.49
RIPK2 O43353 1/20 0.49
ABCB11 O95342 1/20 0.49
ABL1 P00519 1/20 0.49
EGFR P00533 1/20 0.49
ERBB2 P04626 1/20 0.49
NTRK1 P04629 1/20 0.49
LCK P06239 1/20 0.49
PGR P06401 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5824455 0.93 SRC (0.56) METAXLPDGFRAKDRKIT
SCHEMBL5824950 0.92 PDGFRA (0.54) METAXLPDGFRAKDRKIT
SCHEMBL5825497 0.91 MET (0.54) METAXLPDGFRAKDRKIT
SCHEMBL5824733 0.89 KDR (0.54) METAXLPDGFRAKDRKIT
SCHEMBL5824617 0.88 SRC (0.58) METAXLPDGFRAKDRKIT
SCHEMBL5824611 0.88 MET (0.53) METAXLPDGFRAKDRKIT
SCHEMBL5824946 0.87 AXL (0.54) METAXLPDGFRAKDRKIT
SCHEMBL5824543 0.87 PDGFRA (0.51) METAXLPDGFRAKDRKIT
SCHEMBL5824735 0.87 MET (0.52) METAXLPDGFRAKDRKIT
SCHEMBL5824902 0.87 EGFR (0.50) METAXLPDGFRAKDRKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA MET 84/4885AXL 94/4885PDGFRA 1/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA MET 40/4885AXL 99/4885PDGFRA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.